Y-MABS THERAPEUTICS INC. - COMMON STOCK
13.18
13-11月-24 16:45:00
15 分の遅延
株式
0.00
0.00%
本日の幅
13.10 - 13.59
ISIN
N/A
ソース
NASDAQ
-
Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate Developments
08 11 2024 06:35:00 提供 Nasdaq GlobeNewswire
-
04 11 2024 07:35:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces Third Quarter 2024 Conference Call and Webcast
25 10 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs to Participate in Upcoming Investor Conferences in October
01 10 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
06 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs to Participate in Upcoming Investor Conferences in September
03 9 2024 08:32:32 提供 Nasdaq GlobeNewswire
-
Y-mAbs Reports Second Quarter 2024 Financial Results and Recent Corporate Developments
12 8 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs to Participate in Upcoming Investor Conferences in August
07 8 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces Second Quarter 2024 Conference Call and Webcast
05 8 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Appoints Seasoned Biopharma Executive Peter Pfreundschuh as Chief Financial Officer
01 7 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces Preclinical GD2-SADA Data to be Presented at 2024 SNMMI Annual Meeting
07 6 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
05 6 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
01 6 2024 08:15:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
01 6 2024 08:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
07 5 2024 16:05:01 提供 Nasdaq GlobeNewswire
-
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
26 4 2024 07:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs to Present at 2024 ASCO Annual Meeting
25 4 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
14 3 2024 09:05:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
04 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Y-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
29 2 2024 16:05:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >